Current position:Home >Product >
3-[(R)-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)-morpholin-4-ium-4-yl-methyl]-8-methyl-1H-quinolin-2-one
3-[(R)-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)-morpholin-4-ium-4-yl-methyl]-8-methyl-1H-quinolin-2-one
|
|
Canonical SMILES:
CC1=CC=CC2=C1NC(=O)C(=C2)C(C3=NN=NN3C4CCCCC4)[NH+]5CCOCC5
Isomeric SMILES
CC1=CC=CC2=C1NC(=O)C(=C2)[C@H](C3=NN=NN3C4CCCCC4)[NH+]5CCOCC5
InChI
InChI=1S/C22H28N6O2/c1-15-6-5-7-16-14-18(22(29)23-19(15)16)20(27-10-12-30-13-11-27)21-24-25-26-28(21)17-8-3-2-4-9-17/h5-7,14,17,20H,2-4,8-13H2,1H3,(H,23,29)/p+1/t20-/m1/s1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 3-[(R)-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)-(4-methylpiperazine-1,4-diium-1-yl)methyl]-8-methyl-1H-quinolin-2-one
- 3-[(R)-azepan-1-ium-1-yl-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)methyl]-8-methyl-1H-quinolin-2-one
- 8-methyl-3-[(R)-[1-(phenylmethyl)-1,2,3,4-tetrazol-5-yl]-pyrrolidin-1-ium-1-yl-methyl]-1H-quinolin-2-one
- 8-methyl-3-[(R)-[1-(phenylmethyl)-1,2,3,4-tetrazol-5-yl]-piperidin-1-ium-1-yl-methyl]-1H-quinolin-2-one
- 8-methyl-3-[(R)-morpholin-4-ium-4-yl-[1-(phenylmethyl)-1,2,3,4-tetrazol-5-yl]methyl]-1H-quinolin-2-one
- 8-methyl-3-[(R)-(4-methylpiperazine-1,4-diium-1-yl)-[1-(phenylmethyl)-1,2,3,4-tetrazol-5-yl]methyl]-1H-quinolin-2-one
- 3-[(R)-(4-ethylpiperazine-1,4-diium-1-yl)-[1-(phenylmethyl)-1,2,3,4-tetrazol-5-yl]methyl]-8-methyl-1H-quinolin-2-one
- 8-methyl-3-[(R)-[1-[[(2S)-oxolan-2-yl]methyl]-1,2,3,4-tetrazol-5-yl]-pyrrolidin-1-ium-1-yl-methyl]-1H-quinolin-2-one
- 8-methyl-3-[(R)-[1-[[(2S)-oxolan-2-yl]methyl]-1,2,3,4-tetrazol-5-yl]-piperidin-1-ium-1-yl-methyl]-1H-quinolin-2-one
- 8-methyl-3-[(R)-morpholin-4-ium-4-yl-[1-[[(2S)-oxolan-2-yl]methyl]-1,2,3,4-tetrazol-5-yl]methyl]-1H-quinolin-2-one

